Correction: Pardo-Sánchez et al. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. Cancers 2021, 13, 2980
- 1.
- Figure S1A was uploaded instead of Figure 2A. Thus, Figure 2 should be replaced with the following version:
- 2.
- 3.
- In the Funding Section, acknowledgment to co-funding by ERDF/ESF, “Investing in your future” was missing. The Funding Section should be replaced with the following statement:
- Funding: This research was funded by the Fondo de Investigación Sanitaria, ISCIII, grant numbers PI15-209 and PI20-194, co-funded by ERDF/ESF, “Investing in your future”. J.M.P.-S. was funded by the Ministerio de Educación, Cultura, y Deporte, grant number FPU13/02755.
- 4.
- In addition, some minor typos have been corrected.
Conflicts of Interest
Reference
- Pardo-Sánchez, J.M.; Mancheño, N.; Cerón, J.; Jordá, C.; Ansotegui, E.; Juan, Ó.; Palanca, S.; Cremades, A.; Gandía, C.; Farràs, R. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. Cancers 2021, 13, 2980. [Google Scholar] [CrossRef]
Sample Number | Patient Code | Genetic Alterations (Oncomine™ Focus Assay) | |
---|---|---|---|
#1 | LF01 | ERBB4 c.2139G>T; p.L713F | 9% allele frequency |
#4 | LF05 | KRAS c.34G>T; p.G12C | 67% allele frequency |
#8 | LF09 | KRAS c.34G>T; p.G12C | 7% allele frequency |
#12 | LF15 | KRAS c.34G>T; p.G12C ERBB2 c.2524G>A; p.V842I | 32% allele frequency 4% allele frequency |
#17 | LF20 | ERBB2 c.2301C>G; p.I767M MYC c.77A>G; p.N26S | 74% allele frequency 58% allele frequency |
#26 | LF29 | MET c.3029 C>T; p.T1010I | 29% allele frequency |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pardo-Sánchez, J.M.; Mancheño, N.; Cerón, J.; Jordá, C.; Ansotegui, E.; Juan, Ó.; Palanca, S.; Cremades, A.; Gandía, C.; Farràs, R. Correction: Pardo-Sánchez et al. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. Cancers 2021, 13, 2980. Cancers 2021, 13, 4825. https://doi.org/10.3390/cancers13194825
Pardo-Sánchez JM, Mancheño N, Cerón J, Jordá C, Ansotegui E, Juan Ó, Palanca S, Cremades A, Gandía C, Farràs R. Correction: Pardo-Sánchez et al. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. Cancers 2021, 13, 2980. Cancers. 2021; 13(19):4825. https://doi.org/10.3390/cancers13194825
Chicago/Turabian StylePardo-Sánchez, José Miguel, Nuria Mancheño, José Cerón, Carlos Jordá, Emilio Ansotegui, Óscar Juan, Sarai Palanca, Antonio Cremades, Carolina Gandía, and Rosa Farràs. 2021. "Correction: Pardo-Sánchez et al. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. Cancers 2021, 13, 2980" Cancers 13, no. 19: 4825. https://doi.org/10.3390/cancers13194825
APA StylePardo-Sánchez, J. M., Mancheño, N., Cerón, J., Jordá, C., Ansotegui, E., Juan, Ó., Palanca, S., Cremades, A., Gandía, C., & Farràs, R. (2021). Correction: Pardo-Sánchez et al. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. Cancers 2021, 13, 2980. Cancers, 13(19), 4825. https://doi.org/10.3390/cancers13194825